@article{1aa91927e31e448881061eb757397532,
title = "Antibody-drug conjugates for H3K27M-mutant diffuse midline gliomas: Prospects and challenges",
keywords = "H3K27M, antibody-drug conjugate, convection-enhanced delivery, diffuse intrinsic pontine glioma, diffuse midline glioma, efficacy, half-life, targeted therapy, theragnostic, volume of distribution",
author = "Rechberger, {Julian S.} and {A Power}, Erica and Elena Millesi and Daniels, {David J.}",
note = "Funding Information: EA Power would like to disclose that this publication was supported by Clinical and Translational Science Award (CTSA), grant number TL1 TR002380 from the National Center for Advancing Translational Science (NCATS). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.",
year = "2021",
month = aug,
doi = "10.4155/tde-2021-0045",
language = "English (US)",
volume = "12",
pages = "553--557",
journal = "Therapeutic Delivery",
issn = "2041-5990",
publisher = "Future Science",
number = "8",
}